Insider sale
NEWAMSTERDAM PHARMA CO N.V.
$172.49M
4.50M shares
What this filing means
BCLS II INVESTCO, LP plans to sell 4.50M shares of NEWAMSTERDAM PHARMA CO N.V. valued at approximately $172.49M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 12/2/2025ACC: 0001193125-25-305717
10% Owner
Since Dec 2023
4.50M
Shares to sell
$172.49M
Approx. market value
4.80M
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months2
Purchase of ordinary shares in an underwritten public offering.
Cash
6/9/2023
797.56KPurchase of ordinary shares directly from the Issuer in a private placement.
Cash
11/22/2022
4MTotal acquired4.80M
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
6/9/2023 | Purchase of ordinary shares in an underwritten public offering. Cash | 797.56K | — |
11/22/2022 | Purchase of ordinary shares directly from the Issuer in a private placement. Cash | 4M | — |
| Total | 4.80M | ||
Planned & Completed Dispositions1
NasdaqPlanned
Units to sell
4.50M
Market value
$172.49M
12/2/2025
Total
Units
4.50M
Value
$172.49M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
12/2/2025 | 4.50M | $172.49M | Nasdaq | Planned |
| Total | 4.50M | $172.49M | ||